Beneficiaries
Helmholtz Zentrum München (coordinator) Germany (HMGU)
AstraZenenca AB, Sweden (AstraZeneca)
Bayer Aktiengesellschaft, Germany (Bayer)
Sanofi-Aventis Recherche & Développement, France (Sanofi)
Molecular Networks Gmbh Computerchemie, Germany (MolNet)
Københavns Universitet, Denmark (UCPH)
Université de Strasbourg, France (UNISTRA)
Universiteit Leiden, Netherlands (ULEI)
Istituto di Ricerche Farmacologiche Mario Negri, Italy (IRFMN)
Agencia Estatal Consejo Superior De Investigaciones Científicas, Spain (CSIC)
Technische Universität München, Germany (TUM)
Technische Universiteit Eindhoven, Netherlands (TU/e)
École Normale Supérieure, France (ENS-PSL)
Associated Partners
Università Della Svizzera Italiana, Switzerland (USI)
Ecole Polytechnique Fédérale De Lausanne, Switzerland (EPFL)
Universitat De Barcelona, Spain (UB)
Ascenion GmbH, Germany (Ascenion)
Chelonia SA, Switzerland (Chelonia)
US Food & Drug Administration, United States (FDA)
Korea Institute of Toxicology, South Korea (KIT)
European Chemicals Agency, Finland (ECHA)